The Hepatitis B Treatment Market Volume is on an upward trajectory, with expectations for significant expansion as treatment options diversify and improve. By 2035, the market is forecasted to reach an impressive $10.28 billion, highlighting a compound annual growth rate (CAGR) of 6.97%. The factors propelling this growth include an escalating prevalence of Hepatitis B globally, coupled with...